cyclohexanol has been researched along with Acute Disease in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (8.00) | 18.7374 |
| 1990's | 3 (12.00) | 18.2507 |
| 2000's | 16 (64.00) | 29.6817 |
| 2010's | 4 (16.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berk, M; Dodd, S; Kelin, K; Mancini, M; Schacht, A | 1 |
| Altshuler, LL; Frye, MA; Grunze, H; Hellemann, G; Keck, PE; Kupka, RW; Leverich, GS; McElroy, SL; Nolen, WA; Post, RM; Sugar, CA; Suppes, T | 1 |
| Amr, YM; Yousef, AA | 1 |
| Ilias, I; Karaiskos, D; Liappas, I; Paparrigopoulos, T; Tzavellas, E | 1 |
| Batista, M; Bonbled, F; Capron, A; Dugernier, T; Fonseca, S; Hantson, P; Haufroid, V; Simon, M | 1 |
| Aguglia, E; Albert, U; Bogetto, F; Maina, G | 1 |
| Einen, M; Hecht, M; Kushida, CA; Lin, L; Mignot, E; Taheri, S; Umetsu, DT | 1 |
| Campos, AR; De Araújo, RP; Lima Júnior, RC; Rao, VS; Santos, FA; Silva, RM | 1 |
| Alberich Jordà, M; Battista, N; Delwel, R; Löwenberg, B; Maccarrone, M; Rayman, N; Tas, M; van Lom, K; Verbakel, SE | 1 |
| Dethlefsen, U; Kehrl, W; Sonnemann, U | 1 |
| Hemrick-Luecke, SK; Iyengar, S; Simmons, RM; Webster, AA; Xu, JY | 1 |
| Casciano, R; Chen, J; Geissler, EC; Mallick, R; Panish, JM; Trivedi, MH; Wan, GJ | 1 |
| Altun Ugur, B; Arikan, E; Guldiken, B; Guldiken, S; Kara, M; Tugrul, A | 1 |
| Albano, D; Zajecka, JM | 1 |
| Ezra, DG; Storoni, M; Whitefield, LA | 1 |
| Angus, JA; Tham, SM; Tudor, EM; Wright, CE | 1 |
| Blashki, G; Keks, N | 1 |
| Chen, YC; Lu, RB; Wu, YS | 1 |
| Giertz, H; Richter, W; von Arnim, B | 1 |
| Feighner, J; Mandos, LA; Rickels, K; Schweizer, E | 1 |
| Hwang, W; Kim, KY; Narendran, R | 1 |
| De Clercq, M; Horsmans, Y; Sempoux, C | 1 |
| Blauer, F; Fleisch, MC; Gubler, JG; Kuhn, M; Scherer, TA | 1 |
| Arikian, S; Casciano, J; Casciano, R; Doyle, J | 1 |
| Balzano, E; De Gaetani, G | 1 |
4 review(s) available for cyclohexanol and Acute Disease
| Article | Year |
|---|---|
Treatment response for acute depression is not associated with number of previous episodes: lack of evidence for a clinical staging model for major depressive disorder.
Topics: Acute Disease; Adult; Antidepressive Agents; Citalopram; Cyclohexanols; Depression; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Paroxetine; Recurrence; Thiophenes; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2013 |
SNRIs in the management of acute major depressive disorder.
Topics: Acute Disease; Adrenergic Uptake Inhibitors; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder, Major; Duloxetine Hydrochloride; Humans; Placebos; Randomized Controlled Trials as Topic; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Thiophenes; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
Simultaneous bilateral acute angle closure glaucoma following venlafaxine treatment.
Topics: Acute Disease; Cyclohexanols; Female; Glaucoma, Angle-Closure; Humans; Irritable Bowel Syndrome; Middle Aged; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2006 |
The health economic impact of antidepressant usage from a payer's perspective: a multinational study.
Topics: Acute Disease; Algorithms; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Drug Costs; Europe; Health Care Costs; Health Policy; Humans; North America; Venlafaxine Hydrochloride | 2001 |
7 trial(s) available for cyclohexanol and Acute Disease
| Article | Year |
|---|---|
Impact of antidepressant continuation after acute positive or partial treatment response for bipolar depression: a blinded, randomized study.
Topics: Acute Disease; Adult; Antidepressive Agents; Antimanic Agents; Bipolar Disorder; Bupropion; Cyclohexanols; Demography; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Humans; Male; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2009 |
Evaluation of efficacy of the perioperative administration of Venlafaxine or gabapentin on acute and chronic postmastectomy pain.
Topics: Acute Disease; Adult; Amines; Analgesics; Breast Neoplasms; Chronic Disease; Cyclohexanecarboxylic Acids; Cyclohexanols; Female; Gabapentin; gamma-Aminobutyric Acid; Humans; Mastectomy, Radical; Mastectomy, Segmental; Middle Aged; Morphine; Pain Measurement; Pain, Postoperative; Perioperative Care; Statistics, Nonparametric; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Venlafaxine versus clomipramine in the treatment of obsessive-compulsive disorder: a preliminary single-blind, 12-week, controlled study.
Topics: Acute Disease; Adult; Ambulatory Care; Clomipramine; Cyclohexanols; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Obsessive-Compulsive Disorder; Personality Assessment; Selective Serotonin Reuptake Inhibitors; Single-Blind Method; Treatment Outcome; Venlafaxine Hydrochloride | 2002 |
Therapy for acute nonpurulent rhinosinusitis with cineole: results of a double-blind, randomized, placebo-controlled trial.
Topics: Acute Disease; Adult; Anti-Infective Agents, Local; C-Reactive Protein; Cyclohexanols; Double-Blind Method; Eucalyptol; Female; Humans; Male; Monoterpenes; Prospective Studies; Sinusitis | 2004 |
Venlafaxine vs. paroxetine in the acute phase of treatment for major depressive disorder among Han Chinese population in Taiwan.
Topics: Acute Disease; Adult; Asian People; China; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Paroxetine; Pharmacogenetics; Prospective Studies; Psychiatric Status Rating Scales; Remission Induction; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2007 |
Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients.
Topics: Acute Disease; Adult; Ambulatory Care; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Patient Dropouts; Placebos; Psychiatric Status Rating Scales; Treatment Outcome; Venlafaxine Hydrochloride | 1994 |
[D1-sobrerol in the treatment of acute and chronic bronchopulmonary phlogoses].
Topics: 1-Propanol; Acute Disease; Adolescent; Adult; Aged; Alcohols; Bronchiectasis; Bronchitis; Bronchopneumonia; Chronic Disease; Clinical Trials as Topic; Cyclohexanes; Cyclohexanols; Evaluation Studies as Topic; Humans; Middle Aged; Pulmonary Emphysema; Respiratory Tract Infections | 1973 |
14 other study(ies) available for cyclohexanol and Acute Disease
| Article | Year |
|---|---|
Acute eosinophilic pneumonia after venlafaxine overdose.
Topics: Acute Disease; Adult; Cyclohexanols; Drug Overdose; Humans; Male; Pulmonary Eosinophilia; Venlafaxine Hydrochloride | 2011 |
The spectrum of acute heart failure after venlafaxine overdose.
Topics: Acute Disease; Adult; Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Death, Sudden, Cardiac; Delayed-Action Preparations; Electrocardiography; Epilepsy, Tonic-Clonic; Fatal Outcome; Female; Heart Failure; Humans; Hypoxia; Long QT Syndrome; Middle Aged; Respiration, Artificial; Serotonin Syndrome; Shock, Cardiogenic; Stroke Volume; Suicide, Attempted; Venlafaxine Hydrochloride; Ventricular Function, Left | 2013 |
Report of a case of immunosuppression with prednisone in an 8-year-old boy with an acute onset of hypocretin-deficiency narcolepsy.
Topics: Acute Disease; Benzhydryl Compounds; Carrier Proteins; Central Nervous System Stimulants; Child; Cyclohexanols; HLA Antigens; Humans; Immunosuppressive Agents; Intracellular Signaling Peptides and Proteins; Male; Modafinil; Narcolepsy; Neuropeptides; Orexins; Polysomnography; Prednisone; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2003 |
1,8-cineole (eucalyptol), a monoterpene oxide attenuates the colonic damage in rats on acute TNBS-colitis.
Topics: Acute Disease; Administration, Rectal; Animals; Anti-Inflammatory Agents; Colitis; Colon; Cyclohexanols; Disease Models, Animal; Dose-Response Relationship, Drug; Eucalyptol; Glutathione; Instillation, Drug; Intestinal Mucosa; Male; Monoterpenes; Organ Size; Peroxidase; Rats; Rats, Wistar; Trinitrobenzenesulfonic Acid | 2004 |
The peripheral cannabinoid receptor Cb2, frequently expressed on AML blasts, either induces a neutrophilic differentiation block or confers abnormal migration properties in a ligand-dependent manner.
Topics: Acute Disease; Arachidonic Acids; Bucladesine; Cannabinoid Receptor Modulators; Cell Differentiation; Cell Movement; Cyclic AMP; Cyclohexanols; Down-Regulation; Endocannabinoids; Glycerides; Hematopoietic Stem Cells; Humans; Immunosuppressive Agents; Leukemia, Myeloid; Ligands; MAP Kinase Signaling System; Mutagenesis, Site-Directed; Neutrophils; Pertussis Toxin; Receptor, Cannabinoid, CB2; Receptors, Granulocyte Colony-Stimulating Factor | 2004 |
Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats.
Topics: Acute Disease; Amines; Amitriptyline; Animals; Conscious Sedation; Cyclohexanecarboxylic Acids; Cyclohexanols; Cyclopropanes; Disease Models, Animal; Drug Therapy, Combination; Duloxetine Hydrochloride; Fluoxetine; Formaldehyde; Gabapentin; gamma-Aminobutyric Acid; Male; Methyltyrosines; Milnacipran; Neuromuscular Junction; Norepinephrine; p-Chloroamphetamine; Pain; Paroxetine; Rats; Rats, Sprague-Dawley; Serotonin; Thiophenes; Venlafaxine Hydrochloride | 2004 |
Cost and effectiveness of venlafaxine extended-release and selective serotonin reuptake inhibitors in the acute phase of outpatient treatment for major depressive disorder.
Topics: Activities of Daily Living; Acute Disease; Ambulatory Care; Cost-Benefit Analysis; Cyclohexanols; Decision Support Techniques; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Drug Costs; Female; Fluoxetine; Fluvoxamine; Humans; Male; Paroxetine; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
Complete relief of pain in acute painful diabetic neuropathy of rapid glycaemic control (insulin neuritis) with venlafaxine HCL.
Topics: Acute Disease; Analgesics; Blood Glucose; Cyclohexanols; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Humans; Male; Middle Aged; Pain; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
Synergistic and additive interactions of the cannabinoid agonist CP55,940 with mu opioid receptor and alpha2-adrenoceptor agonists in acute pain models in mice.
Topics: Acute Disease; Adrenergic alpha-Agonists; Analgesics; Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Cannabinoids; Cyclohexanols; Dexmedetomidine; Dose-Response Relationship, Drug; Drug Synergism; Injections, Spinal; Male; Mice; Morphine; Pain; Pain Measurement; Receptors, Opioid, mu | 2005 |
The acutely psychotic patient--assessment and initial management.
Topics: Acute Disease; Adolescent; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Aripiprazole; Cyclohexanols; Female; Humans; Male; Physicians, Family; Piperazines; Practice Guidelines as Topic; Psychotic Disorders; Quinolones; Referral and Consultation; Risk Assessment; Venlafaxine Hydrochloride | 2006 |
[Double-blind clinical trial of tramadol capsules. First communication: Comparison with pentazocine and placebo (author's transl)].
Topics: Acute Disease; Adult; Aged; Cyclohexanols; Double-Blind Method; Female; Humans; Male; Middle Aged; Pain; Pentazocine; Tramadol | 1981 |
Acute liver damage possibly related to sertraline and venlafaxine ingestion.
Topics: Acute Disease; Adult; Antidepressive Agents; Cephalexin; Cephalosporins; Chemical and Drug Induced Liver Injury; Cyclohexanols; Drug Overdose; Humans; Male; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicide, Attempted; Venlafaxine Hydrochloride | 1999 |
Venlafaxine-associated hepatitis.
Topics: Acute Disease; Adult; Antidepressive Agents, Second-Generation; Chemical and Drug Induced Liver Injury; Cyclohexanols; Female; Humans; Venlafaxine Hydrochloride | 1999 |
Eosinophilic pneumonia and respiratory failure associated with venlafaxine treatment.
Topics: Acute Disease; Adult; Antidepressive Agents, Second-Generation; Biopsy; Cyclohexanols; Depressive Disorder, Major; Humans; Lung; Male; Prednisone; Pulmonary Eosinophilia; Respiratory Insufficiency; Tomography, X-Ray Computed; Venlafaxine Hydrochloride | 2000 |